Filing Details
- Accession Number:
- 0001209191-15-070517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-14 16:08:57
- Reporting Period:
- 2015-09-10
- Filing Date:
- 2015-09-14
- Accepted Time:
- 2015-09-14 16:08:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578251 | T. Jeffrey Walsh | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-10 | 11,000 | $5.50 | 11,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-10 | 824 | $128.11 | 10,176 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-10 | 7,624 | $129.97 | 2,552 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-10 | 2,552 | $130.79 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-09-10 | 11,000 | $0.00 | 11,000 | $5.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 92,151 | 2023-01-16 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2014.
- The range of prices for the transaction reported on this line was $128.00 to $128.58. The average weighted price was $128.1138. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $129.50 to $130.50. The average weighted price was $129.9706. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $130.52 to $131.42. The average weighted price was $130.7919. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
Billionaire Hedge Funds
